These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Exhaustive computational search of ionic-charge clusters that mediate interactions between mammalian cytochrome P450 (CYP) and P450-oxidoreductase (POR) proteins. Zawaira A; Gallotta M; Beeton-Kempen N; Coulson L; Marais P; Kuttel M; Blackburn J Comput Biol Chem; 2010 Feb; 34(1):42-52. PubMed ID: 19939736 [TBL] [Abstract][Full Text] [Related]
7. RNA-interference approach to study functions of NADPH : cytochrome P450 oxidoreductase in human hepatocytes. Feidt DM; Klein K; Nüssler A; Zanger UM Chem Biodivers; 2009 Nov; 6(11):2084-91. PubMed ID: 19937842 [TBL] [Abstract][Full Text] [Related]
8. A second FMN binding site in yeast NADPH-cytochrome P450 reductase suggests a mechanism of electron transfer by diflavin reductases. Lamb DC; Kim Y; Yermalitskaya LV; Yermalitsky VN; Lepesheva GI; Kelly SL; Waterman MR; Podust LM Structure; 2006 Jan; 14(1):51-61. PubMed ID: 16407065 [TBL] [Abstract][Full Text] [Related]
9. Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking. Li W; Tang Y; Liu H; Cheng J; Zhu W; Jiang H Proteins; 2008 May; 71(2):938-49. PubMed ID: 18004755 [TBL] [Abstract][Full Text] [Related]
10. Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase. Pandey AV; Kempná P; Hofer G; Mullis PE; Flück CE Mol Endocrinol; 2007 Oct; 21(10):2579-95. PubMed ID: 17595315 [TBL] [Abstract][Full Text] [Related]
11. Conformational dynamics and the energetics of protein--ligand interactions: role of interdomain loop in human cytochrome P450 reductase. Grunau A; Geraki K; Grossmann JG; Gutierrez A Biochemistry; 2007 Jul; 46(28):8244-55. PubMed ID: 17580970 [TBL] [Abstract][Full Text] [Related]
12. P450 oxidoreductase: genotyping, expression, purification of recombinant protein, and activity assessments of wild-type and mutant protein. Agrawal V; Miller WL Methods Mol Biol; 2013; 987():225-37. PubMed ID: 23475681 [TBL] [Abstract][Full Text] [Related]
13. Effect of genetic variation on human cytochrome p450 reductase-mediated paraquat cytotoxicity. Han JF; Wang SL; He XY; Liu CY; Hong JY Toxicol Sci; 2006 May; 91(1):42-8. PubMed ID: 16495354 [TBL] [Abstract][Full Text] [Related]
14. [Antley-Bixler syndrome or POR deficiency?]. Tomková M; Marohnic CC; Baxová A; Martásek P Cas Lek Cesk; 2008; 147(5):261-5. PubMed ID: 18630181 [TBL] [Abstract][Full Text] [Related]
15. Class-dependent sequence alignment strategy improves the structural and functional modeling of P450s. Baudry J; Rupasinghe S; Schuler MA Protein Eng Des Sel; 2006 Aug; 19(8):345-53. PubMed ID: 16777908 [TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of the NADPH cytochrome P450 reductase gene (CPR) from Candida bombicola. Van Bogaert IN; Develter D; Soetaert W; Vandamme EJ FEMS Yeast Res; 2007 Sep; 7(6):922-8. PubMed ID: 17559413 [TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of P450 oxidoreductase: implications in drug metabolism and therapy. Hu L; Zhuo W; He YJ; Zhou HH; Fan L Pharmacogenet Genomics; 2012 Nov; 22(11):812-9. PubMed ID: 23047293 [TBL] [Abstract][Full Text] [Related]
19. Rescue of cytochrome P450 oxidoreductase (Por) mouse mutants reveals functions in vasculogenesis, brain and limb patterning linked to retinoic acid homeostasis. Ribes V; Otto DM; Dickmann L; Schmidt K; Schuhbaur B; Henderson C; Blomhoff R; Wolf CR; Tickle C; Dollé P Dev Biol; 2007 Mar; 303(1):66-81. PubMed ID: 17126317 [TBL] [Abstract][Full Text] [Related]
20. Evolution of NADPH-cytochrome P450 oxidoreductases (POR) in Apiales - POR 1 is missing. Andersen TB; Hansen NB; Laursen T; Weitzel C; Simonsen HT Mol Phylogenet Evol; 2016 May; 98():21-8. PubMed ID: 26854662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]